Market Watch Weekly | November 20th, 2020 | Welcome to the Masquerade

Erik Dekker - Nov 21, 2020
It was another positive week for global equities in what was almost a mirror image of last week’s trading pattern. Equities got off to a roaring start on Monday after Moderna announced preliminary trial data that showed its coronavirus vaccine...

It was another positive week for global equities in what was almost a mirror image of last week’s trading pattern. Equities got off to a roaring start on Monday after Moderna announced preliminary trial data that showed its coronavirus vaccine is more than 94% effective – the 2nd such vaccine in just seven days. At this juncture, Pfizer and BioNTech, which announced the same result last Monday, have now applied for an emergency use authorization from the Food and Drug Administration (FDA) for their vaccine. Moderna is expected to follow suit next week. The FDA process is expected to take a few weeks, and an advisory committee meeting to review the vaccine has been tentatively scheduled for early December. After almost 10 months of uncertainty, we now know Americans could get their first dose of the vaccine in about a month.

Click here for the full report.